Monopar Therapeutics Inc. Banner Image

Monopar Therapeutics Inc.

  • Ticker MNPR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Monopar Therapeutics Inc. Logo Image
  • 1-10 Employees
  • Based in Wilmette, Illinois
Monopar Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar's pipeline consists of Validive® for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced softMore tissue sarcoma; and a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19.
Monopar Therapeutics Inc.

Most Recent Annual Report

Monopar Therapeutics Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports